Do age of onset and course of illness predict different treatment outcome among DSM IV depressive disorders with atypical features?

被引:36
作者
Stewart, JW [1 ]
McGrath, PJ [1 ]
Quitkin, FM [1 ]
机构
[1] New York State Psychiat Inst & Hosp, New York, NY 10032 USA
关键词
atypical features; depression; tricyclic; monoamine oxidase inihibitor; age of onset; course of illness;
D O I
10.1016/S0893-133X(01)00313-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
DSM IV defines its atypical features depression modifier mainly by current symptoms, Relative to depressed patients with melancholic features, those with atypical features often present with earlier onset of a more chronic disorder and are less likely to benefit from tricyclic antidepressant (TCA). We, therefore, hypothesized that within depressed patients with atypical features those with illness cow-se most similar to that of melancholia would be most TCA-responsive, those Whose illness course least resembled that Of melancholia would be least TCA responsive. Two patient groups were treated with TCA, monoamine oxidase inhibitor, or placebo with nonresponders crossed to alternative treatment. One group met DSM IV criteria for atypical features and the other nearly met these criteria. Early onset, chronically depressed patients with DSM IV atypical features had poor TCA response relative to others. Patients with "probable" atypical features (mood reactivity phis one associated atypical feature) and non-responders crossed to alternate treatment confirmed this. Findings suggest that application of DSM IV atypical features might best be limited to those with early onset of chronic dysphoria. (C) 2002 American College of Neuropsychopharmacology. Published by Elsevier Science Inc.
引用
收藏
页码:237 / 245
页数:9
相关论文
共 38 条
  • [1] American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT, P5
  • [2] ASNIS GM, 1995, AM J PSYCHIAT, V152, P31
  • [3] BIELSKI RJ, 1976, ARCH GEN PSYCHIAT, V33, P1479
  • [4] The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder
    Bouffard, R
    Hechtman, L
    Minde, K
    Iaboni-Kassab, F
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (08): : 546 - 554
  • [5] BROWN WA, 1994, NEUROPSYCHOPHARMACOL, V10, P265, DOI 10.1038/npp.1994.53
  • [6] CEREBRAL LATERALITY AND DEPRESSION - DIFFERENCES IN PERCEPTUAL ASYMMETRY AMONG DIAGNOSTIC SUBTYPES
    BRUDER, GE
    QUITKIN, FM
    STEWART, JW
    MARTIN, C
    VOGLMAIER, MM
    HARRISON, WM
    [J]. JOURNAL OF ABNORMAL PSYCHOLOGY, 1989, 98 (02) : 177 - 186
  • [7] Falkai P, 1999, J CLIN PSYCHIAT, V60, P36
  • [8] Critical review of tricyclic antidepressant use in children and adolescents
    Geller, B
    Reising, D
    Leonard, HL
    Riddle, MA
    Walsh, BT
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1999, 38 (05) : 513 - 516
  • [9] Guy W., 1976, ECDEU ASSESSMENT MAN, P534
  • [10] A RATING SCALE FOR DEPRESSION
    HAMILTON, M
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1960, 23 (01) : 56 - 62